Nucliq Biologics — Investor Overview

Nucliq Biologics Inc.

Microbiome intelligence platform for gut health & women's hormonal wellness — Canada, India, UAE, USA

🧬 Microbiome 💊 Preventive Health 🤖 AI/ML ♀️ Women's Health Halifax, NS Seed / Pre-Series A

🔬

Gutcheck™

Comprehensive at-home gut microbiome test for digestive & metabolic health. 87% of patients report satisfactory symptom connection.

♀️

Gutcheck™ VIVO

The world's only gut test built for women's hormonal health — PCOS, endometriosis, menopause, fertility. Estrobolome intelligence.

🛡️

Insurance-Backed

Medavie Blue Cross coverage secured — first insurance-reimbursed microbiome test in North America. Eliminates the #1 adoption barrier.

$1M+

Revenue since launch (Sep 2022)

92%

Would highly recommend Gutcheck™

25+

Private clinic & healthcare partners

140K+

Phenotypic data points collected

Revenue Trajectory

2025 Revenue

$275K

Achieved

→

2026 Run Rate

>$480K

Already achieved ARR

→

18-Month Target

$2.5–3M

Annualized revenue

Company Details

Founded2019
StageSeed / Pre-Series A
Raise$2M
MarketsCanada, India, UAE, USA
ApprovalHealth Canada MDEL (Class I)
InsuranceMedavie Blue Cross

Leadership Team

CEO / Co-founderDr. Nikitha Kendyala, PhD
CTO / Co-founderDr. Purvikalyan Pallegar, PhD
ML EngineerDr. Shazia Janwari, PhD
Sr BioinformaticianFarida Samad-zada, MSc
Lab OperationsDr. Luke Bown, PhD
Team Size14 members

Use of Funds — $2M Seed / Pre-Series A

38%

$760K

Commercial Growth & Sales

17%

$340K

International Expansion

15%

$300K

Product & Technology

15%

$300K

Drug Discovery & IP

10%

$200K

Operations & Regulatory

$100K

Working Capital

📄 What's in the Investor Overview

Enter your details below to unlock the full Nucliq Biologics investor deck.

📊 Market size & $20B+ opportunity

💰 $2M raise & use of funds

🧬 AI platform & therapeutic pipeline

🌏 India, UAE & US expansion plan

🔓 Unlock the Investor Overview

Enter your details below to access the Nucliq Biologics investor deck. For accredited investors and interested parties only.

First Name *

Last Name *

Email Address *

Organization / Fund (optional)

I consent to receiving occasional updates and investment opportunities from North Founders. Unsubscribe anytime. (Privacy Policy)

I consent to Nucliq Biologics contacting me with information relevant to this investment opportunity.

✅ I have read and understood the disclaimer below and confirm any investment decision I make will be based on my own independent due diligence. (Required)

🔒 Your information is secure and will never be sold.

✅

You're in. Here's the deck.

A copy has also been sent to your email. Welcome to the North Founders investor network.

⬇️ Download Nucliq Biologics Investor Deck

📧 Also sent to your inbox — check spam if you don't see it within a few minutes.

⚠️ Important Disclaimer — Please Read

The information on this page and in the accompanying document is provided by North Founders for informational purposes only and does not constitute financial, investment, legal, or tax advice.

North Founders is not a registered investment dealer, broker-dealer, or investment adviser. Nothing herein should be construed as a recommendation, solicitation, or offer to buy or sell securities. North Founders does not endorse, recommend, or guarantee the suitability of any investment in Nucliq Biologics Inc. or any other company featured on this platform.

Investing in early-stage companies involves significant risk, including the potential for total loss of capital. Any individual who chooses to invest does so entirely at their own risk, based on their own independent analysis and due diligence. North Founders accepts no liability for any investment decisions made in reliance on this information.

This page is intended for accredited investors and sophisticated parties only under applicable Canadian securities laws. If you have questions about your eligibility to invest, consult a qualified financial or legal professional.

Canada's firstinsurance-reimbursed gut microbiome platform.